Mesothelioma and asbestos information needed to know today

The often lethal, rare cancer mesothelioma usually from malignant cells of lung cancer that is widely known as a place approved that includes the result of exposure to asbestos. Asbestos and mesothelioma information you can feel better, this cancer before it's too late. Over the years more than 80 percent of all cases of mesothelioma asbestos were joined in. Those suffering from mesothelioma usually aComplaint of chest pain, turn to a doctor for testing. During these investigations it is common to find that many of the symptoms have been thought of mesothelioma from other diseases. Abdominal pain, breathing difficulties and bottlenecks, and even anemia can be attributed to other causes. Therefore mesothelioma and asbestos information is important in order to create a correct diagnosis.

- Asbestos lung mesothelioma

Where a patient has no symptoms ofMesothelioma can be identified or suspected after physical examination, the cancer spread and to keep getting worse. As the cancer progresses through the stages of untreated, is weight loss, shortness of breath, loss of appetite and night sweats. Here are some facts and diagnosis of mesothelioma.

Mesothelioma and asbestos information needed to know today

The often lethal, rare cancer mesothelioma usually from malignant cells of lung cancer that is widely known as a place approved that includes the result of exposure to asbestos. Asbestos and mesothelioma information you can feel better, this cancer before it's too late. Over the years more than 80 percent of all cases of mesothelioma asbestos were joined in. Those suffering from mesothelioma usually aComplaint of chest pain, turn to a doctor for testing. During these investigations it is common to find that many of the symptoms have been thought of mesothelioma from other diseases. Abdominal pain, breathing difficulties and bottlenecks, and even anemia can be attributed to other causes. Therefore mesothelioma and asbestos information is important in order to create a correct diagnosis.

- Asbestos lung mesothelioma

Where a patient has no symptoms ofMesothelioma can be identified or suspected after physical examination, the cancer spread and to keep getting worse. As the cancer progresses through the stages of untreated, is weight loss, shortness of breath, loss of appetite and night sweats. Here are some facts and diagnosis of mesothelioma.

Information-Your Number Key For Coping With Mesothelioma Cancer

After you receive a diagnosis of mesothelioma you number one priority should be to get adequate information about the disease so that you can make the right informed decisions on the necessary steps you need to take.



When looking for information about mesothelioma cancer, first know what type of mesothelioma you have,the pleural mesothelioma is the commonest but there are also other types of mesothelioma depending on the part of the body that is affected by the cancer. Talk with your health care team. Ask them for information about your specific type of cancer, including the cell type and the stage (extent) of your cancer. This is helpful because your cancer treatment will be designed for just you.



The stage of the cancer, as well as other factors, will help determine the goal of treatment. Most types of mesothelioma cancer treatment have 1 of these 3 goals: provide a cure, control the disease, or ease symptoms of the cancer and help make the patient comfortable. Sometimes the treatment goal changes after treatment has started. Talk with your doctor, and make sure you understand what your treatment options are, so you can make the best decisions for you and your family.



We live in an information-packed age. Cancer information can be complex and confusing. To find accurate and up-to-date information, use reliable sources, such as journals or Web sites from well-respected cancer centers, national cancer organizations, health professional organizations.One good source of information is www.mesotheliomacorner.blogspot.com, you will find the necessary information you need in a very easy to understand manner.



Look for information that has been reviewed by medical experts, is updated often, and states the purpose of the information. When you get information, discuss it with your health care team to find out if and how it applies to you. Remember, written information cannot take the place of medical advice from your doctor or cancer care team.

Information-Your Number Key For Coping With Mesothelioma Cancer

After you receive a diagnosis of mesothelioma you number one priority should be to get adequate information about the disease so that you can make the right informed decisions on the necessary steps you need to take.



When looking for information about mesothelioma cancer, first know what type of mesothelioma you have,the pleural mesothelioma is the commonest but there are also other types of mesothelioma depending on the part of the body that is affected by the cancer. Talk with your health care team. Ask them for information about your specific type of cancer, including the cell type and the stage (extent) of your cancer. This is helpful because your cancer treatment will be designed for just you.



The stage of the cancer, as well as other factors, will help determine the goal of treatment. Most types of mesothelioma cancer treatment have 1 of these 3 goals: provide a cure, control the disease, or ease symptoms of the cancer and help make the patient comfortable. Sometimes the treatment goal changes after treatment has started. Talk with your doctor, and make sure you understand what your treatment options are, so you can make the best decisions for you and your family.



We live in an information-packed age. Cancer information can be complex and confusing. To find accurate and up-to-date information, use reliable sources, such as journals or Web sites from well-respected cancer centers, national cancer organizations, health professional organizations.One good source of information is www.mesotheliomacorner.blogspot.com, you will find the necessary information you need in a very easy to understand manner.



Look for information that has been reviewed by medical experts, is updated often, and states the purpose of the information. When you get information, discuss it with your health care team to find out if and how it applies to you. Remember, written information cannot take the place of medical advice from your doctor or cancer care team.

Virginia Employees At-Risk For Asbestos Diseases Should Seek Periodic Medical Exams

Workers who have a history of asbestos exposure in Virginia should be checked often for asbestos-related illnesses. Those who worked in the armed forces, refineries, auto factories, shipyards and chemical plants in Virginia??before the 1980s should tell their doctors about their potential exposure to asbestos. Early detection is important in many cases of asbestos-related diseases, as even lung cancers have a better prognosis when caught early.

Caused by the inhalation of asbestos fibers, asbestosis is a scarring of the lower lobes of the lungs. Virginia workers who were employed in certain industries, such as shipbuilding, automotive repairs and mining, should be on alert for asbestosis and other asbestos-related diseases. At-risk workers in Virginia who have a history of asbestos exposure should see their physicians for periodic asbestosis screenings. To detect asbestosis, the physician will take an x-ray of the lungs, which will be evaluated by a certified radiologist. This diagnostic tool can establish whether the patient has scarred lung tissue, which is often associated with asbestos exposure. Although asbestosis is not typically deadly, it can become progressive and may require the patient to depend on inhalers. Patients who have been diagnosed with asbestosis should undergo regular x-rays and lung function tests to track the development of the disease.

Shipyards Asbestos Exposure and the Mesothelioma Menace

Asbestos is a naturally occurring mineral that was widely used in a variety of products.?? Asbestos only becomes dangerous when it is broken into small pieces that become airborne.?? When these small pieces of asbestos dust are inhaled they settle into the lungs and can cause life threatening diseases.?? One interesting study is called, "Screening for asbestos-induced diseases in Finland" by Kari Koskinen, MD, Jouko-Pekka Rinne, MD, Anders Zitting, MD, Antti Tossavainen, DTech, Jukka Kivek??s, MD, Kari Reijula, MD, Pekka Roto, MD, MIH, Matti S. Huuskonen, MD, MSc - Finnish Institute of Occupational Health, Helsinki, Finland - American Journal of Industrial Medicine - Volume 30 Issue 3, Pages 241 – 251.?? Here is an excerpt: "Abstract - Screening for asbestos-induced diseases in Finland was carried out in 1990-1992 as a part of the Asbestos Program of the Finnish Institute of Occupational Health. The aim of the present study was to find the workers who had developed an asbestos-induced disease in certain occupations. Examination of active or retired workers included a personal interview on work history and asbestos exposure, and a chest X-ray. The target group for the screening comprised workers under 70 years of age who had worked at least for 10 years in construction, 1 year in a shipyard or in the manufacture of asbestos products. A preliminary questionnaire was sent to 54,409 workers, 18,943 of whom finally participated in the screening examination. The mean age of the workers was 53 years; 95% were employed in construction, 2% in shipyards, and 3% in the asbestos industry. The criteria for a positive screening result were (1) a radiographic finding clearly indicating lung fibrosis (at least ILO category 1/1), (2) a radiographic finding indicating mild lung fibrosis (ILO category I/O) with unilateral or bilateral pleural plaques, (3) marked abnormalities of the visceral pleura (marked adhesions with or without pleural thickening), or (4) bilateral pleural plaques. The positive cases totalled 4,133 (22%) and were sent for further investigation. In addition to the screening, information on the presence of asbestos in the work environment, prevention of asbestos exposure, as well as on the health effects of asbestos exposure and smoking were given to the participating workers. The screening acted as a preliminary survey to prompt further national follow-up of asbestos-induced diseases among the workers who have been exposed to asbestos. This article presents the material, methods, and overall results of the screening. ??

A second study is called, "Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers." By Lesur O, Bernard AM, Bégin RO - Unité de Recherche Pulmonaire, Université de Sherbrooke, Québec, Canada.?? Chest. 1996 Feb;109(2):467-74.?? Here is an excerpt: "Abstract - Asbestos-exposed workers (Asb) can sometimes develop lung impairments resembling idiopathic pulmonary fibrosis (IPF). Smoking is often a troubling confounder in the natural history of these lung diseases. Distal airspace epithelial cells, which are also altered in asbestosis, secrete Clara cell protein (CC-16, also designated CC-10) and surfactant-associated protein A (SP-A). By inhibiting phospholipase A2 (PLA2), CC-16 and SP-A are putative candidates for controlling lung inflammatory events. Both were measured with PLA2 activity in alveolar fluids (and sera for CC-16) of smoker and nonsmoker Asb and compared with smoking-matched normal subjects (N). CC-16 (in mg/L) was slightly increased in Asb and affected by smoking: nonsmoker Asb: 3.1 +/- 0.5 vs nonsmoker N: 1.9 +/- 0.2 (p < 0.05), smoker Asb: 1.7 +/- 0.3 vs smoker N: 0.6 +/- 0.1 (p < 0.05). SP-A (in microgram/mL) was enhanced in Asb but not affected by smoking: 5.4 +/- 1.5 in Asb vs 1.6 +/- 0.4 in N (p < 0.05), whereas SP-A to phosphorus ratio was increased in Asb but affected by smoking. CC-16 to albumin and CC-16 in serum to alveolar fluid ratios were altered by cigarette consumption in Asb (p < 0.05 vs N). Secretory PLA2 activity was slightly enhanced in Asb (p < 0.05 vs N). All data were similar between stages of disease. In summary, alveolar CC-16, SP-A, and secretory PLA2 activity were increased in Asb. Smoking affected several parameters. By this habit, Asb might reinforce lung profibrotic factors and increase their risk in developing lung alterations resembling IPF."

If you found any of these studies interesting, please read them in their entirety.?? We all owe a great deal of thanks to the people who are researching these important issues.

Shipyards Asbestos Exposure and the Mesothelioma Menace

Asbestos is a naturally occurring mineral that was widely used in a variety of products.?? Asbestos only becomes dangerous when it is broken into small pieces that become airborne.?? When these small pieces of asbestos dust are inhaled they settle into the lungs and can cause life threatening diseases.?? One interesting study is called, "Screening for asbestos-induced diseases in Finland" by Kari Koskinen, MD, Jouko-Pekka Rinne, MD, Anders Zitting, MD, Antti Tossavainen, DTech, Jukka Kivek??s, MD, Kari Reijula, MD, Pekka Roto, MD, MIH, Matti S. Huuskonen, MD, MSc - Finnish Institute of Occupational Health, Helsinki, Finland - American Journal of Industrial Medicine - Volume 30 Issue 3, Pages 241 – 251.?? Here is an excerpt: "Abstract - Screening for asbestos-induced diseases in Finland was carried out in 1990-1992 as a part of the Asbestos Program of the Finnish Institute of Occupational Health. The aim of the present study was to find the workers who had developed an asbestos-induced disease in certain occupations. Examination of active or retired workers included a personal interview on work history and asbestos exposure, and a chest X-ray. The target group for the screening comprised workers under 70 years of age who had worked at least for 10 years in construction, 1 year in a shipyard or in the manufacture of asbestos products. A preliminary questionnaire was sent to 54,409 workers, 18,943 of whom finally participated in the screening examination. The mean age of the workers was 53 years; 95% were employed in construction, 2% in shipyards, and 3% in the asbestos industry. The criteria for a positive screening result were (1) a radiographic finding clearly indicating lung fibrosis (at least ILO category 1/1), (2) a radiographic finding indicating mild lung fibrosis (ILO category I/O) with unilateral or bilateral pleural plaques, (3) marked abnormalities of the visceral pleura (marked adhesions with or without pleural thickening), or (4) bilateral pleural plaques. The positive cases totalled 4,133 (22%) and were sent for further investigation. In addition to the screening, information on the presence of asbestos in the work environment, prevention of asbestos exposure, as well as on the health effects of asbestos exposure and smoking were given to the participating workers. The screening acted as a preliminary survey to prompt further national follow-up of asbestos-induced diseases among the workers who have been exposed to asbestos. This article presents the material, methods, and overall results of the screening. ??

A second study is called, "Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers." By Lesur O, Bernard AM, Bégin RO - Unité de Recherche Pulmonaire, Université de Sherbrooke, Québec, Canada.?? Chest. 1996 Feb;109(2):467-74.?? Here is an excerpt: "Abstract - Asbestos-exposed workers (Asb) can sometimes develop lung impairments resembling idiopathic pulmonary fibrosis (IPF). Smoking is often a troubling confounder in the natural history of these lung diseases. Distal airspace epithelial cells, which are also altered in asbestosis, secrete Clara cell protein (CC-16, also designated CC-10) and surfactant-associated protein A (SP-A). By inhibiting phospholipase A2 (PLA2), CC-16 and SP-A are putative candidates for controlling lung inflammatory events. Both were measured with PLA2 activity in alveolar fluids (and sera for CC-16) of smoker and nonsmoker Asb and compared with smoking-matched normal subjects (N). CC-16 (in mg/L) was slightly increased in Asb and affected by smoking: nonsmoker Asb: 3.1 +/- 0.5 vs nonsmoker N: 1.9 +/- 0.2 (p < 0.05), smoker Asb: 1.7 +/- 0.3 vs smoker N: 0.6 +/- 0.1 (p < 0.05). SP-A (in microgram/mL) was enhanced in Asb but not affected by smoking: 5.4 +/- 1.5 in Asb vs 1.6 +/- 0.4 in N (p < 0.05), whereas SP-A to phosphorus ratio was increased in Asb but affected by smoking. CC-16 to albumin and CC-16 in serum to alveolar fluid ratios were altered by cigarette consumption in Asb (p < 0.05 vs N). Secretory PLA2 activity was slightly enhanced in Asb (p < 0.05 vs N). All data were similar between stages of disease. In summary, alveolar CC-16, SP-A, and secretory PLA2 activity were increased in Asb. Smoking affected several parameters. By this habit, Asb might reinforce lung profibrotic factors and increase their risk in developing lung alterations resembling IPF."

If you found any of these studies interesting, please read them in their entirety.?? We all owe a great deal of thanks to the people who are researching these important issues.